Teladoc Health, Inc. (TDOC)

Over the past six months, Teladoc Health's stock price has declined. The share price was $5.27 as of April 8, 2026, a 33.12% decrease from April 9, 2025. Recent events include the Fourth Quarter and Full Year 2025 Earnings Report, where Q4 revenue was flat year-over-year, and the net loss topped estimates. Several analysts adjusted their ratings and price targets for TDOC in March 2026. CEO Charles Divita III sold 27,731 shares of the company's stock on March 11, 2026. Teladoc's stock declined by 2.86% on April 10, 2026, underperforming the S&P 500.

The demand for Teladoc Health's products and services, particularly within its BetterHelp segment, has historically experienced seasonal churn. Teladoc Health is actively working to mitigate this seasonality by shifting BetterHelp towards an insurance-reimbursement-based model, which aims to create a more stable and less seasonal demand for BetterHelp's services.

Teladoc Health, Inc., founded in 2002 and headquartered in New York City, is a telemedicine and virtual healthcare company operating in the Health Information Services industry. It connects patients, providers, and healthcare systems through technology-enabled platforms, offering a range of virtual care services, including general medical, expert medical services, specialty medical, chronic condition management, mental health, primary care, prescriptions, and medical opinions. The company operates through two segments: Teladoc Health Integrated Care, which provides global virtual medical services on a B2B basis, and BetterHelp, which focuses on direct-to-consumer virtual mental health care. Teladoc Health's family of brands includes Teladoc, Advance Medical, Catapult Health, Uplift, Best Doctors, Livongo, BetterHelp, BetterSleep, InTouch Health, Telecare, MédecinDirect, and HealthiestYou.

Teladoc Health has a significant global presence, serving over 175 countries. While an American company, it has expanded into Asian, European, and Latin American countries through strategic mergers and acquisitions. The company's global network comprises approximately 40,000 medical professionals and 5,000 employees.

Teladoc Health is described as the global leader in virtual care, aiming to transform how better health happens by delivering and orchestrating care across patients, providers, platforms, and partners. The company focuses on enabling greater access to care, driving better outcomes, extending provider capacity, and lowering costs through its relationships with health plans, employers, providers, health systems, and consumers. Teladoc Health has been working to improve its business model, particularly within its BetterHelp segment, by transitioning to a higher-margin, data-driven B2B platform with a focus on insurance reimbursement.

Teladoc Health's ownership is primarily held by institutional shareholders, who own approximately 74.16% of the company. Retail investors hold about 18.81%, and Teladoc Health insiders own 7.04%. Major institutional owners include Vanguard Group Inc and BlackRock, Inc. HLM Venture Partners II LP is noted as the largest individual Teladoc Health shareholder.